Advanced search
Publication Cover
Acta Orthopaedica Volume 86, 2015 - Issue 4
Journal homepage
1,522
Views
34
CrossRef citations to date
0
Altmetric
Original Articles

Increased risk of revision for infection in rheumatoid arthritis patients with total hip replacements

A study of 390,671 primary arthroplasties from the Nordic Arthroplasty Register Association

Johannes Cornelis SchramaThe Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University HospitalCorrespondence[email protected]
,
Anne M FenstadThe Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University HospitalCorrespondence[email protected]
,
Håvard DaleThe Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University HospitalCorrespondence[email protected]
,
Leif HavelinThe Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University Hospital;Department of Clinical Medicine, University of Bergen, Bergen, NorwayCorrespondence[email protected]
,
Geir HallanThe Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University HospitalCorrespondence[email protected]
,
Søren OvergaardDepartment of Orthopaedic Surgery and Traumatology, Odense University Hospital;Institute of Clinical Research, University of Southern Denmark, OdenseCorrespondence[email protected]
,
Alma B PedersenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, DenmarkCorrespondence[email protected]
,
Johan KärrholmThe Swedish Hip Arthroplasty Register, Registercentrum VGR and Department of Orthopaedics, Institute of Surgical Science, Sahlgrenska University Hospital, Gothenburg University, Mölndal, SwedenCorrespondence[email protected]
,
Göran GarellickThe Swedish Hip Arthroplasty Register, Registercentrum VGR and Department of Orthopaedics, Institute of Surgical Science, Sahlgrenska University Hospital, Gothenburg University, Mölndal, SwedenCorrespondence[email protected]
,
Pekka PulkkinenDepartment of Public Health, University of Helsinki, HelsinkiCorrespondence[email protected]
,
Antti EskelinenThe Coxa Hospital for Joint Replacement, TampereCorrespondence[email protected]
,
Keijo MäkeläDepartment of Orthopaedics and Traumatology, Turku University Hospital, Turku, FinlandCorrespondence[email protected]
,
Lars B EngesæterThe Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University Hospital;Department of Clinical Medicine, University of Bergen, Bergen, NorwayCorrespondence[email protected]
&
Bjørg-Tilde FevangThe Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University Hospital;Department of Rheumatology, Haukeland University Hospital, Bergen, NorwayCorrespondence[email protected]
 show all
Pages 469-476 | Received 30 Aug 2014, Accepted 05 Jan 2015, Published online: 17 Mar 2015

  • Ainscow DA, Denham RA. The risk of haematogenous infection in total joint replacements. J Bone Joint Surg Br 1984; 66(4): 580–2.
  • Akkara Veetil BM, Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol 2012; 8(1): 32–41.
  • Au K, Reed G, Curtis JR, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis 2011; 70(5): 785–91.
  • Berthold E, Geborek P, Gulfe A. Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures. Acta Orthop 2013; 84(5): 495–501.
  • Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. Jama 2006; 295(19): 2275–85.
  • Bongartz T, Halligan CS, Osmon DR, et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 2008; 59(12): 1713–20.
  • Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am 1975; 6(4): 991–1003.
  • Dale H, Fenstad AM, Hallan G, et al. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop 2012; 83(5): 449–58.
  • den Broeder AA, Creemers MC, Fransen J, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol 2007; 34(4): 689–95.
  • Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002; 46(9): 2287–93.
  • Espehaug B, Furnes O, Havelin LI, Engesaeter LB, Vollset SE, Kindseth O. Registration completeness in the Norwegian Arthroplasty Register. Acta Orthop 2006; 77(1): 49–56.
  • Fevang BT, Lie SA, Havelin LI, Engesaeter LB, Furnes O. Reduction in orthopedic surgery among patients with chronic inflammatory joint disease in Norway 1994. Arthritis Rheum 2007; 57(3): 529–32.
  • Fitzgerald RHJr.,Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA2nd, Coventry MB, . Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am 1977; 59(7): 847–55.
  • Giles JT, Bartlett SJ, Gelber AC, et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 2006; 55(2): 333–7.
  • Gilson M, Gossec L, Mariette X, et al. Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor alpha-blockers: a case-control study. Arthritis Res Ther 2010; 12(4): R145.
  • Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000; 71(4): 337–53.
  • Havelin LI, Fenstad AM, Salomonsson R, et al. The Nordic Arthroplasty Register Association: a unique collaboration between 3 national hip arthroplasty registries with 280,201 THRs. Acta Orthop 2009; 80(4): 393–401.
  • Hjardem E, Hetland ML, Ostergaard M, Krogh NS, Kvien TK, Danish Database for Biological Therapies in Rheumatology Study G. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent. Ann Rheum Dis 2005; 64(8): 1220–3.
  • Jamsen E, Virta LJ, Hakala M, Kauppi MJ, Malmivaara A, Lehto MU. The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: a nationwide register-based study from 1995. Acta Orthop 2013; 84(4): 331–7.
  • Josefsson G, Kolmert L. Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1,688 hips. Clin Orthop Relat Res 1993; (292): 210–4.
  • Kapetanovic MC, Lindqvist E, Saxne T, Eberhardt K. Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement. Ann Rheum Dis 2008; 67(10): 1412–6.
  • Kawakami K, Ikari K, Kawamura K, et al. Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications? Rheumatology (Oxford) 2010; 49(2): 341–7.
  • Komano Y, Tanaka M, Nanki T, et al. and Group RS. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety. J Rheumatol 2011; 38(7): 1258–64.
  • Kvien TK, Heiberg, Lie E, et al. A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 2005; 23(Suppl 39):S188-94
  • Lie SA, Engesaeter LB, Havelin LI, Gjessing HK, Vollset SE. Dependency issues in survival analyses of 55,782 primary hip replacements from 47,355 patients. Stat Med 2004; 23(20): 3227–40.
  • Lindgren JV, Gordon M, Wretenberg P, Karrholm J, Garellick G. Validation of reoperations due to infection in the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord 2014; 15(1): 384.
  • Lucht U. The Danish Hip Arthroplasty Register. Acta Orthop Scand 2000; 71(5): 433–9.
  • Makela KT, Matilainen M, Pulkkinen P, et al. Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ 2014a; 348: f7592.
  • Makela KT, Matilainen M, Pulkkinen P, et al. Countrywise results of total hip replacement. Acta Orthop 2014b; 85(2): 107–16.
  • Malchau H, Herberts P, Eisler T, Garellick G, Soderman P. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am 2002; 84-A (Suppl 2): 2–20.
  • Momohara S, Kawakami K, Iwamoto T, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol 2011; 21(5): 469–75.
  • Mutru O, Laakso M, Isomaki H, Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 1985; 290(6484): 1797–9.
  • Nordstrom DC, Konttinen L, Korpela M, et al. Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience. Rheumatol Int 2006; 26(8): 741–8.
  • Oga M, Sugioka Y, Hobgood CD, Gristina AG, Myrvik QN. Surgical biomaterials and differential colonization by Staphylococcus epidermidis. Biomaterials 1988; 9(3): 285–9.
  • Paavolainen P, Hamalainen M, Mustonen H, Slatis P. Registration of arthroplasties in Finland. A nationwide prospective project. Acta Orthop Scand Suppl 1991; 241: 27–30.
  • Pedersen A, Johnsen S, Overgaard S, Soballe K, Sorensen HT, Lucht U. Registration in the Danish Hip Arthroplasty Registry: completeness of total hip arthroplasties and positive predictive value of registered diagnosis and postoperative complications. Acta Orthop Scand 2004; 75(4): 434–41.
  • Pedersen AB, Svendsson JE, Johnsen SP, Riis A, Overgaard S. Risk factors for revision due to infection after primary total hip arthroplasty. A population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop 2010; 81(5): 542–7.
  • Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res 1984; (182): 117–26.
  • Ranstam J, Robertsson O. Statistical analysis of arthroplasty register data. Acta Orthop 2010; 81(1): 10–4.
  • Rud-Sorensen C, Pedersen AB, Johnsen SP, Riis AH, Overgaard S. Survival of primary total hip arthroplasty in rheumatoid arthritis patients. Acta Orthop 2010; 81(1): 60–5.
  • Ruyssen-Witrand A, Gossec L, Salliot C, et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol 2007; 25(3): 430–6.
  • Schrama JC, Espehaug B, Hallan G, et al. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken) 2010; 62(4): 473–9.
  • Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010a; 69(4): 631–7.
  • Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010b; 69(6): 964–75.
  • Soderlin MK, Geborek P. Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follow-up of 1839 patients in southern Sweden. Ann Rheum Dis 2008; 67(1
  • Soderman P, Malchau H, Herberts P, Johnell O. Are the findings in the Swedish National Total Hip Arthroplasty Register valid? A comparison between the Swedish National Total Hip Arthroplasty Register, the National Discharge Register, and the National Death Register. J Arthroplasty 2000; 15(7): 884–9.
  • Stinchfield FE, Bigliani LU, Neu HC, Goss TP, Foster CR. Late hematogenous infection of total joint replacement. J Bone Joint Surg Am 1980; 62(8): 1345–50.
  • Suzuki M, Nishida K, Soen S, et al. Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association. J Orthop Sci 2011; 16(6): 778–84.
  • Talwalkar SC, Grennan DM, Gray J, Johnson P, Hayton MJ. Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery. Ann Rheum Dis 2005; 64(4): 650–1.
  • Vermeer M, Kuper HH, Hoekstra M, et al. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study. Arthritis Rheum 2011; 63(10): 2865–72.
  • Wendling D, Balblanc JC, Brousse A, et al. Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures. Ann Rheum Dis 2005; 64(9): 1378–9.
  • Winthrop KL, Yamashita S, Beekmann SE, Polgreen PM, Infectious Diseases Society of America Emerging Infections N. Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin Infect Dis 2008; 46(11): 1738–40.
  • Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998; 41(6): 1072–82.
  • Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351(16): 1645–54.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.